Comment by
tdon1229 on Dec 23, 2020 6:56pm
And when they realize that CCR5 is over expressed in the brains of stroke victims, maybe they'll get still another trial opportunity with leronlimab, which is a CCR5 agonist.
Comment by
Rumpl3StiltSkin on Dec 24, 2020 10:10am
Great discussion guys, Merry Christmas! I really hope that TLT can figure out how to roll out a Covid therapeutic that is simple to use in the clinics. We know 1433 is safe. We also know it should be effective. I also believe it can be used as a preventative? And it shouldn't matter too much what Covid 19 morphs into?
Comment by
charlierock on Dec 24, 2020 11:49am
The potential for 1433 being applied to Covid and other viruses is very exciting. My major concerns are funding, research and clinical trials moving at glacier speed. Any kind of good news for this application would be icing on the cake. Let's hope 2021 brings the goods!